RECOGNITION AND ASSESSMENT

  • Presentation of infective endocarditis (IE) is highly variable and can affect almost any organ system
  • A high index of suspicion is required in the febrile patient with significant risk factors
  • Clinical presentation of IE is changing and classic findings, such as haemorrhagic lesions, are becoming less common.
  • Consider a diagnosis of endocarditis in all patients presenting with bacteraemia without an obvious source, especially if the patient has one of the risk factors outlined below

Symptoms and signs

  • Non-specific and of insidious onset
  • Lethargy
  • Nausea, vomiting
  • Anorexia, weight loss
  • Fever, night sweats
  • Shortness of breath
  • Musculoskeletal pain
  • Haemorrhagic lesions:
    • mucocutaneous petechiae
    • Janeway lesions (painless, haemorrhagic, macular plaques most frequently seen on palms and soles of feet)
    • Roth spots (small, retinal haemorrhages with pale centres, seen near optic nerve)
    • splinter haemorrhages
  • Anaemia
  • Clubbing (if prolonged disease)
  • Splenomegaly
  • New mitral, aortic or tricuspid murmur
  • New embolic event which is unexplained

Risk factors

  • Previous IE
  • Cardiovascular disease, especially:
    • ventricular septal defect
    • aortic regurgitation
    • mitral regurgitation
    • aortic stenosis
    • patent ductus arteriosus
    • coarctation of aorta
  • Prosthetic heart valve
  • IV drug use (right sided valve lesions more common)
  • Immunosuppressed patients
  • Indwelling IV catheter
  • Rheumatic heart disease

Blood Cultures

  • Aseptic technique is vital. Follow Collection of blood culture specimens guideline
  • Draw each sample at >1 hr intervals by separate venepuncture and not from an indwelling catheter
  • If patient is IV drug user, or has prosthetic heart valve or central venous catheter, consider fungal cultures. State suspicion of endocarditis on form; blood culture will then be incubated for 3 weeks
  • Inform microbiologist of suspected IE

Patient has severe sepsis or septic shock

  • Take 2 separate sets of blood cultures and administer empirical antimicrobials within 1 hr of diagnosis

Patient acutely ill

  • Take 3 sets of blood cultures within first 24 hr before starting antimicrobial therapy with at least 1 hr interval between each set (one aerobic and one anaerobic bottle per set)
    • do not delay antimicrobial therapy in acutely ill patients

Patient not acutely ill

  • Take 3 sets of blood cultures within first 48 hr
  • If patient not acutely ill but antimicrobials have already been commenced, discontinue antimicrobial therapy and take 2 sets of blood cultures daily for 3 days (6 sets)

Other investigations

  • FBC and differential WCC:
    • look for leucocytosis, usually with neutrophilia
    • look for anaemia, usually normochromic normocytic
  • ESR
  • CRP
  • Complement C3, C4, CH50
  • ECG, look for conduction defects such as first or second degree block
  • Urinalysis, look for protein and microscopic haematuria
  • Consider echocardiography in patients on the basis of a balanced clinical assessment by a suitable experienced senior clinician

Diagnostic criteria

  • See Duke classification

Select all relevant criteria and tap calculate when complete

Duke's major clinical criteria

  • Typical micro-organisms from 2 separate blood cultures
    • Strep. viridans, Strep. bovis, Haemophilus spp., Cardiobacterium hominis, Eikenella spp. or Kingella spp. or Kingella spp. or
    • community-acquired Staph. aureus or enterococci, in the absence of a primary focus
  • Blood culture persistently positive for organisms consistent with IE
    • 2 positive cultures drawn >12 hr apart or
    • all of 3, or majority of >4 cultures (where first sample and last sample drawn >1 hr apart)
  • Positive echocardiogram for IE
    • oscillating intracardiac mass on valve or supporting structures or
    • abscess or
    • new partial dehiscence of prosthetic valve
  • New valvular regurgitation
  • Q-fever (Coxiella burnetii) or
  • e.g. Bartonella, Chlamydia psittaci

Duke's minor clinical criteria

IMMEDIATE TREATMENT

  • Once diagnosis confirmed or highly likely based on the Duke classification, arrange transfer to cardiology ward with on-call cardiology team
  • In an ill patient, after blood cultures taken, do not wait for blood culture report or echocardiographic confirmation. Start empirical treatment
Check blood cultures taken

Penicillin Allergy

  • Ask the patient and record what happened when they were given penicillin
    • True penicillin allergy is rare
    • In IE, alternative antimicrobials are less effective with greater risks attached
  • If any doubt about whether patient is truly allergic to penicillin, seek advice from a microbiologist or consultant in infectious diseases
Accept penicillin allergy as genuine hypersensitivity only if history of either rash within 72 hr of dose or anaphylactic reaction is convincing

Infection Control alerts

  • Check for IC alert
    • If IC alert not available, check previous 12 months of microbiology reports
  • If MRSA present, treat as tagged for MRSA. See MRSA management
  • if ESBL, MGNB, CARB present, treat as tagged for ESBL. See ESBL/MGNB/CARG management

Empirical Anti-microbial Treatment

Types of Endocarditis - Select one from list

  • First line: Amoxicillin 2 g IV 4-hrly
  • Alternative (true penicillin allergy): Vancomycin IV by infusion (see Vancomycin calculator and guideline)
  • Vancomycin (see Vancomycin calculator and guideline) plus gentamicin 3 mg/kg IV once daily; see Adjunctive once-daily gentamicin (3 mg/kg) for infective endocarditis
  • If there are concerns about nephrotoxicity, seek advice from consultant microbiologist/ID
  • Vancomycin (see Vancomycin calculator and guideline) plus meropenem 2 g IV 8-hrly
  • Vancomycin (see Vancomycin guideline)
    plus gentamicin 3 mg/kg IV; see Adjunctive once-daily gentamicin (3 mg/kg) for infective endocarditis
    plus rifampicin 600 mg oral (if unable to swallow or absorb oral drugs, IV by infusion) 12-hrly
  • If there are concerns about nephrotoxicity, seek advice from consultant mircobilogist/ID

SUBSEQUENT MANAGEMENT

  • Monitor serum concentrations of vancomycin and gentamicin to avoid toxicity
  • Monitor for signs of deafness and balance problems which may occur at normal levels

Culture positive

  • Direct choice of antimicrobials by results of blood culture and sensitivity with guidance of a microbiologist and/or infectious diseases consultant
  • Treat prosthetic valve endocarditis for at least 6 weeks

Culture negative

  • Up to 30% of all cases of IE are blood culture negative
  • Failure to culture may be explained by:
    • pre-treatment with antimicrobials
    • inadequate number/poor quality of samples
    • infection with atypical pathogen, (e.g. Chlamydia, Coxiella burnetii, Brucella spp., Bartonella spp, Legionella spp, Tropheryma whipplei)
    • infection with a fastidious organism (e.g. members of the HACEK group)
  • Continue antimicrobials in definite or probable IE
  • In case of cardiac surgery, surgeon to send a tissue from valvular biopsy to microbiology requesting ‘PCR to identify causative organism’
  • In patients with negative blood cultures, vegetations, metastatic infection, perivalvular invasion or embolism, consider candida or aspergillus. Consult microbiologist
  • Seek opinion of cardiologist and microbiologist for advice on need for serology, culture with special media and subsequent treatment

MONITORING TREATMENT

  • ESR can remain raised for up to four weeks
  • Temperature usually settles within first 2–4 days, and a subsequent rise may indicate uncontrolled infection but may also indicate antimicrobial resistance, or superinfection with another pathogen
  • In cases of aortic valve endocarditis, repeat ECG daily – looking for development of conduction defect (prolonged PR interval)
  • Repeat echocardiogram weekly on cardiology advice

Complications

  • Heart failure
  • Vegetation embolisation, threatening limbs/organs and/or leading to metastatic abscess (pneumonia/lung abscess in right-sided disease)
  • Abscess in aortic valve ring – can produce heart block
  • Immune complex disease – vasculitic rash, arthritis, glomerulonephritis

Early surgical intervention indicated

  • Decision to undertake valve surgery as part of treatment of infective endocarditis can be extremely challenging. Early consultation will help the timing of surgery – consider an early referral where there is:
    • development of heart failure from acute, severe, valvular regurgitation
    • evidence of annular or aortic abscess (prolongation of PR interval on daily ECG)
    • evidence of significant valve dysfunction and persistent infection after 7–10 days of appropriate antimicrobial treatment
    • early prosthetic valve endocarditis (within 2 months of surgery)
    • Staph. aureus prosthetic valve endocarditis
    • resistant infection, especially associated with prosthetic valve
    • fungal endocarditis
    • large vegetations (>10 mm)

DISCHARGE AND FOLLOW-UP

  • Arrange discharge in consultation with cardiology, infectious diseases and microbiology teams involved. Decision will be based on:
    • settling of physical signs
    • improvement in appetite
    • patient’s sense of wellbeing
    • improvement in inflammatory marker (even if still raised)
  • Arrange out-patient follow-up in cardiology clinic. Arrange to repeat inflammatory markers and, if possible, echocardiogram before this appointment
  • Discuss follow-up with patient. Emphasise need for antimicrobial prophylaxis for future dental and surgical procedures

© 2022 The Bedside Clinical Guidelines Partnership.

Created by University Hospital North Midlands and Keele University School of Computing and Mathematics.

Research and development team: James Mitchell, Ed de Quincey, Charles Pantin, Naveed Mustfa